In April 2017, the College Board approved a four-year recommended implementation plan to adopt the new model standards for pharmacy compounding recently released by the National Association of Pharmacy Regulatory Authorities (NAPRA): Model Standards for Pharmacy Compounding of Non-hazardous Sterile Preparations, and Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations.
Clozapine is a used to treat severe schizophrenia and schizoaffective disorder. While it is an effective antipsychotic, patients using clozapine have a small but significant risk of developing agranulocytosis (severe lack of white-blood cells).
Learn about the Provincial Opioid Addiction Treatment Support Program (POATSP) and Online Addiction Medicine Diploma developed by the BC Centre on Substance Use (BCCSU).
Pharmacy education in British Columbia and Canada continues to advance with the profession. Over the past several decades many pharmacists have earned the Doctor of Pharmacy (PharmD) degree through UBC’s Graduate PharmD Program, or other full-time or part-time programs in the US or other provinces. Learn more about the most recent addition to pharmacy education in BC: UBC’s recently approved Flexible Doctor of Pharmacy (Flex PharmD) degree program
Drug interactions between antiretroviral drugs and other medications can result in loss of therapeutic efficacy or drug toxicity.
At its June 2017 meeting, the College Board approved the modification of the Pharmacy Professionals Review Focus Areas for Pharmacy Technicians in community practice to make them more applicable to their scope of practice.
The new focus areas are now aligned with those for pharmacy technicians in hospital practice.
Responding to an opioid overdose emergency is a stressful experience. The individual overdosing may be a friend, colleague, or family member. We know in stressful circumstances, it’s hard to remember what you need to do and in what order. Strong, clear, and consistent training is essential to ensure that the person responding to an opioid overdose can provide the best care and get the best outcome.
On April 21, 2017, new minimum requirements to enhance the security of community pharmacies in BC were brought into effect. These measures are important to prevent pharmacy robberies and break and enters, and better protect personal health information.
The BC Centre on Substance Use (BCCSU), in collaboration with the BC Ministry of Health, has released a new Guideline for the Clinical Management of Opioid Use Disorder. Effective June 5, 2017, this guideline is the provincial reference tool for all health care professionals in BC involved in treating patients with opioid use disorders.
To increase the transparency and awareness of the complaints process, the College has developed a suite of new resources.